About NunaBio

NunaBio produces synthetic DNA constructs for life sciences and biotechnology research. Using a proprietary enzymatic, cell-free platform, the company manufactures challenging genetic sequences that cannot be efficiently produced through traditional plasmid-based methods, delivering material at production scale in days rather than weeks. The technology addresses a critical bottleneck in synthetic biology, gene therapy, diagnostics, and biomarker development. By eliminating process redevelopment between small and large orders, NunaBio enables researchers and biotech companies to move from concept to application faster, supporting advances in T cell engineering, viral vector synthesis, and precision medicine.